Biblio Discovery — Demo Discovery Service

4 results for "Annette Orleth"

Showing 1–4 · 0.13 seconds · RSS

  1. Journal Article

    Generating evidence on a risk-based monitoring approach in the academic setting – lessons learned

    Belinda von Niederhäusern; Annette Orleth; Sabine Schädelin et al.

    BMC Medical Research Methodology, Vol. 17 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background In spite of efforts to employ risk-based strategies to increase monitoring efficiency in the academic setting, empirical evidence on their effectiveness remains sparse. This mixed-methods study aimed to evaluate the risk-based on-site monitoring approach currently followed at…

  2. Journal Article

    MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial

    Perrine Janiaud; Chiara Zecca; Anke Salmen et al.

    Trials, Vol. 25 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Treatment decisions for persons with relapsing–remitting multiple sclerosis (RRMS) rely on clinical and radiological disease activity, the benefit-harm profile of drug therapy, and preferences of patients and physicians. However, there is limited evidence to support…

  3. Journal Article Full text

    Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

    Stephanie L. Meier; Eline A.J. Willemse; Sabine A. Schaedelin et al.

    JAMA Neurology · 2023 · English · OpenAlex Scopus

    Importance: There is a lack of validated biomarkers for disability progression independent of relapse activity (PIRA) in multiple sclerosis (MS). Objective: To determine how serum glial fibrillary acidic protein (sGFAP) and serum neurofilament light chain (sNfL) correlate with features of disease…